To include your compound in the COVID-19 Resource Center, submit it here.

Lilly CEO pushes Part D rebate revamp

David Ricks, chairman and CEO of Eli Lilly and Co. (NYSE:LLY), Wednesday strongly endorsed proposals for CMS to

Read the full 180 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE